Work

P-227 Safety and clinical activity of ruxolitinib combined with carfilzomib and dexamethasone for patients with carfilzomib-refractory multiple myeloma: results from a phase 1 clinical trial

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01845-1

Authors: Shebli Atrash, James Symanowski, Sarah Norek, Xhevahire Begic, Manisha Bhutani, Barry Paul, Cindy Varga, Andrew Kin, Jeffrey, Peter Voorhees, Saad Usmani

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387003680

Cites:

Cited by:

Related to: 10